Article

OBJECTIVE: To validate the QuickDASH as a patient-reported outcome measure for
assessing upper extremity disability in breast cancer survivors. DESIGN: Large
cross-sectional survey. SETTING: Ambulatory care center at a university hospital.
PARTICIPANTS: Postmenopausal women (N=150) with stage I to III hormone
receptor-positive breast cancer currently taking a third-generation aromatase
inhibitor. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: QuickDASH, an
11-item self-administered questionnaire, assesses global arm function over the
past 7 days. RESULTS: Of 150 surveys, 148 (99%) were scorable. The factor
analysis demonstrated 1 factor with an eigenvalue of 6.7, which explains 61% of
variance. The score was reliable with a Cronbach alpha of .93. The test-retest
reliability was .78 over 2 weeks. The mean QuickDASH score +/- SD for all
patients was 19+/-19. Those with upper extremity arthralgias reported higher
QuickDASH scores than controls without pain (26 vs 12, P=.001). Those with frozen
shoulder pain also reported higher QuickDASH scores than controls without pain
(37 vs 15, P=.001). CONCLUSIONS: The QuickDASH instrument is a convenient,
reliable, and valid patient-reported outcome measure to assess upper extremity
disability in patients with breast cancer.
CI - Copyright (c) 2014 American Congress of Rehabilitation Medicine. Published by
Elsevier Inc. All rights reserved.

Langue : ANGLAIS